期刊文献+

炔诺酮片溶出度测定方法学研究

Determination of the dissolution for Norethisterone Tablets
下载PDF
导出
摘要 目的建立炔诺酮片溶出度检查方法。方法采用桨法进行溶出度实验,高效液相色谱法测定介质中药物含量。结果溶出度检查方法为桨法,以5g.L-1十二烷基硫酸钠溶液500mL为溶出介质,转速为75r.min-1,取样时间为45min(薄膜衣片)或60min(糖衣片)。含量测定方法的线性方程为Y=64 743 X-208(r=1.000 0),在0.12~1.84μg.mL-1质量浓度范围内线性关系良好(r=1.000);A企业样品平均回收率为100.1%,RSD为1.3%,B企业样品平均回收率为100.8%,RSD为0.7%。结论该方法准确可靠,适用于该制剂的质量控制。 Objective To establish a method for the determination of the dissolution rate of Norethisterone Tablets.Methods The method Ⅱ described in the appendix ⅩC of Chinese Pharmacopoeia(2010) was carried out and the HPLC method was adopted for detection of the dissolution rate.Results 500 mL of 5 g·L-1 SDS was used as a solvent with rotating speed of a paddle at 75 r·min-1.The sampling time was 45 min(film coated tablets) or 60 min(sugar-coat tablets) and was quantitatively analyzed by HPLC.The regression equation of norethisterone was Y=64 743X-208(r=1.000 0).The average recovery of norethisterone was 100.1%,with RSD of 1.3%(samples of factory A) and 100.8%,with RSD of 0.7%(samples of factory B).Conclusion The method is accurate and suitable for the dissolution determination for Norethisterone Tablets.
出处 《西北药学杂志》 CAS 2012年第6期569-571,共3页 Northwest Pharmaceutical Journal
关键词 炔诺酮片 溶出度 高效液相色谱法 Norethisterone Tablets dissolution HPLC
  • 相关文献

参考文献5

二级参考文献18

  • 1邱家学.充分利用EXCEL数据处理功能巧算Weibull分布位置参数[J].药学进展,2004,28(10):464-466. 被引量:33
  • 2国家药典委员会.中国药典2005年版[s].二部.北京:化学工业出版社,2005:290.
  • 3国家药典委员会编.中国药典[S].二部.北京:中国医药科技出版社,2010,237.a.
  • 4The United States Pharmacopeial Convention [J]. United State Pharmacopoeia(31) :462.
  • 5Kennedy SH, Andersen HF, Thase ME. Escitalopram in the treatment of major depressive disorder:a meta-analysis[J].Curt Med Res Opin,2009,25(1):161-175.
  • 6Levy MA, Brandt M, Sheedy KM, et al. Epristeride is a selective and specific uncompetitive inhibitor of human steroid 5 alpha - reductase isoform 2. J Steroid Biochem Mol Biol, 1994,48 ( 2 - 3 ) : 197.
  • 7Qian LH, Wang XL, TuZH. Atrophy and apoptosis in ventral prostate of rats induced by 5 α - reductase inhibitor, epristeride. Acta Pharmacol Sin. 2001,22 (5) :399.
  • 8ChP(中国药典).2005.Vol II(二部):Appendix(附录)XC.73.
  • 9ChP(中国药典).2005.Vol II(二部).Appendix(附录)X IX B.
  • 10The Dissolution Procedure Development and Validation. Pharmacopeial Forum,2004, 30( 1 ) :351.

共引文献67

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部